{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Billerica",
      "state": "MA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65244",
      "recalling_firm": "Pharmalucence, Inc.",
      "address_1": "29 Dunham Rd",
      "address_2": "N/A",
      "postal_code": "01821",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide & Bahamas, Barbados, Bermuda, Japan",
      "recall_number": "D-808-2013",
      "product_description": "Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2,  Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821",
      "product_quantity": "17,260 vials",
      "reason_for_recall": "Presence of Particulate Matter; particulate found in retain samples",
      "recall_initiation_date": "20130530",
      "center_classification_date": "20130719",
      "termination_date": "20131017",
      "report_date": "20130731",
      "code_info": "Lot 280011, Exp 08/13",
      "more_code_info": ""
    }
  ]
}